2017
DOI: 10.1097/iae.0000000000001857
|View full text |Cite
|
Sign up to set email alerts
|

Gemcitabine-Induced Retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 3 publications
0
2
0
1
Order By: Relevance
“…Some studies have reported retinopathy associated with the use of this chemotherapeutic agent. One study demonstrated that one patient had several issues related to use of gemcitabine, such as a decrease in vision with appearance of cotton wool spots and intraretinal hemorrhages [ 133 ]. Another case report described that one patient had macular infarction after chemotherapy with gemcitabine and carboplatin [ 134 ].…”
Section: Drugs and Medicinementioning
confidence: 99%
“…Some studies have reported retinopathy associated with the use of this chemotherapeutic agent. One study demonstrated that one patient had several issues related to use of gemcitabine, such as a decrease in vision with appearance of cotton wool spots and intraretinal hemorrhages [ 133 ]. Another case report described that one patient had macular infarction after chemotherapy with gemcitabine and carboplatin [ 134 ].…”
Section: Drugs and Medicinementioning
confidence: 99%
“…It usually causes retinopathy characterized by cottonwool spots and intraretinal hemorrhages with or without subretinal fluid. [269][270][271][272][273] Its appearance has been described as Purtscher-like by some and simply as ischemic vasculopathy by others. Disruption of the outer retina and uveal effusion was reported in 1 case.…”
Section: Diagnostic Testingmentioning
confidence: 99%
“…53 yaşında duktal karsinomu tanısı olan olguda çok sayıda cotton-wool spotları, intraretinal hemorajiler ve maküler eksudasyon olduğunu göstermişler, gemsitabin tedavisinin kesilmesinin ardından ek olarak bevacizumab uygulaması ile görme keskinliğinde artış olduğunu ve retinal lezyonların gerilediğini bildirmişlerdir. [9] Tüm bildirilen olgular göz önünde bulundurulduğunda gemsitabin terapisi başlanan olguların özellikle de beraberinde diyabet ve karotis arter hastalığı gibi ek sistemik risk faktörleri de varsa retinal vasküler değişiklikler açısında dikkatle incelenmesi ve takip edilmesi gerekmektedir. Tespit edilmiş retinal toksisite sonrası hastayı takip eden onkolog ile konsültasyon ve ilacın zamanında sonlandırılması retinal patolojilerde gerileme sağlamaktadır.…”
Section: Gemsitabinunclassified